[Chinese multidisciplinary collaborative expert consensus for the diagnosis and treatment of Budd-Chiari syndrome...

Area of Science:

• Hepatology
• Vascular Medicine
• Clinical Practice Guidelines

Background:

• Budd-Chiari syndrome (B-CS) is a complex hepatic vascular disease resulting from hepatic venous outflow obstruction.
• Significant variations exist in the pathogenesis and treatment of B-CS between China and Western countries.
• Unique epidemiological and clinical characteristics of B-CS in China necessitate tailored management strategies.

Purpose of the Study:

• To establish a multidisciplinary expert consensus for the diagnosis and treatment of Budd-Chiari syndrome in China.
• To provide updated guidance reflecting the specific features of B-CS prevalent in the Chinese population.
• To standardize and enhance the comprehensive management and research of B-CS within China.

Main Methods:

• A collaborative effort by domestic experts from the Professional Committee of Chinese Research Hospital Association.
• Formulation of a consensus based on the current research status of B-CS in China.
• Elaboration on epidemiology, pathogenesis, classification, clinical manifestations, diagnosis, and treatment.

Main Results:

• The consensus details the current understanding of B-CS epidemiology and pathogenesis in China.
• It outlines standardized approaches for clinical classification, diagnosis, and treatment.
• Identifies future research directions, emphasizing basic and high-level evidence clinical studies.

Conclusions:

• The 2021 version provides crucial guidance for clinicians managing B-CS in China.
• It aims to standardize and improve the overall diagnosis and treatment of B-CS.
• Encourages further basic and clinical research to advance the field in China.